These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34428507)

  • 21. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.
    MacKenzie FM; Bruce J; Struelens MJ; Goossens H; Mollison J; Gould IM;
    Clin Microbiol Infect; 2007 Mar; 13(3):269-76. PubMed ID: 17391381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRSA prevalence and hospital-level antibiotic use: A retrospective study across 122 acute-care hospitals.
    Livorsi DJ; Nair R; Lund BC; Alexander B; Beck BF; Goto M; Perencevich EN
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):353-355. PubMed ID: 32938506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship.
    Mergenhagen KA; Starr KE; Wattengel BA; Lesse AJ; Sumon Z; Sellick JA
    Clin Infect Dis; 2020 Aug; 71(5):1142-1148. PubMed ID: 31573026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of intervention for carbapenems and anti-methicillin-resistant Staphylococcus aureus antibiotics by an antimicrobial stewardship team.
    Kagami K; Ishiguro N; Yamada T; Niinuma Y; Iwasaki S; Taki K; Fukumoto T; Hayasaka K; Nishida M; Sugita J; Teshima T; Sugawara M; Takekuma Y
    Am J Infect Control; 2021 Dec; 49(12):1493-1498. PubMed ID: 34416316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings.
    Kardas-Sloma L; Boëlle PY; Opatowski L; Brun-Buisson C; Guillemot D; Temime L
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4888-95. PubMed ID: 21788461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of methicillin-resistant Staphylococcus aureus infection and empirical antibiotic therapy for MRSA infection: multicenter investigation.
    Deng LJ; Wu XD; Kang Y; Xu Y; Zhou JX; Wang DF; Chen DC
    Chin Med J (Engl); 2013; 126(19):3745-9. PubMed ID: 24112175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
    Patel N; Lubanski P; Ferro S; Bonafede M; Harrington S; Evans A; Stellrecht K; Lodise TP
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5141-4. PubMed ID: 19805558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Is Driving the Epidemiology of Methicillin-Resistant
    Borg MA; Camilleri L
    Microb Drug Resist; 2021 Jul; 27(7):889-894. PubMed ID: 33337277
    [No Abstract]   [Full Text] [Related]  

  • 29. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
    Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.
    Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A
    J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis.
    Parienti JJ; Cattoir V; Thibon P; Lebouvier G; Verdon R; Daubin C; du Cheyron D; Leclercq R; Charbonneau P
    J Hosp Infect; 2011 Jun; 78(2):118-22. PubMed ID: 21497946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection.
    Bally M; Dendukuri N; Sinclair A; Ahern SP; Poisson M; Brophy J
    Int J Antimicrob Agents; 2012 Dec; 40(6):479-95. PubMed ID: 23102749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.
    Hsueh PR; Chen WH; Teng LJ; Luh KT
    Int J Antimicrob Agents; 2005 Jul; 26(1):43-9. PubMed ID: 15975769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.
    Reveles KR; Duhon BM; Moore RJ; Hand EO; Howell CK
    PLoS One; 2016; 11(8):e0161658. PubMed ID: 27556897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings.
    Aldeyab MA; Scott MG; Kearney MP; Alahmadi YM; Magee FA; Conlon G; McElnay JC
    Epidemiol Infect; 2014 Mar; 142(3):494-500. PubMed ID: 23735079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.
    Aldeyab MA; Monnet DL; López-Lozano JM; Hughes CM; Scott MG; Kearney MP; Magee FA; McElnay JC
    J Antimicrob Chemother; 2008 Sep; 62(3):593-600. PubMed ID: 18467307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on daptomycin use and implementation of an antimicrobial stewardship program.
    Castel C; de La Blanchardière A; Michon J; Cattoir V; Saint-Lorant G
    Int J Clin Pharm; 2016 Apr; 38(2):421-8. PubMed ID: 26951119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.
    McKinnell JA; Corman S; Patel D; Leung GH; Gordon LM; Lodise TP
    Clin Ther; 2018 Mar; 40(3):406-414.e2. PubMed ID: 29454592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.